Coronary Artery Disease Risk Indicator From Acoustic Heart Signals
QMW is the FDA product code for Coronary Artery Disease Risk Indicator From Acoustic Heart Signals, a class II device type, regulated under 21 CFR 870.1420. FDA's definition for this code reads: "A coronary artery disease risk indicator using acoustic heart signals is a device that records heart sounds including murmurs and vibrations to calculate a patient-specific risk of presence of coronary artery disease, as an aid in cardiac analysis and diagnosis". As of , FDA records hold one 510(k) clearance under this code, the most recent dated , and no recalls.
Classification record
- Product code
- QMW
- Device name
- Coronary Artery Disease Risk Indicator From Acoustic Heart Signals
- FDA definition
- A coronary artery disease risk indicator using acoustic heart signals is a device that records heart sounds including murmurs and vibrations to calculate a patient-specific risk of presence of coronary artery disease, as an aid in cardiac analysis and diagnosis.
- Regulation
- 21 CFR 870.1420
- Device class
- Class II
- Review panel
- Cardiovascular
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 1
- Ingested recalls
- 0
Clearances, product code QMW
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2020 | 1 |
Applicants with the most clearances
Product code QMW| Applicant | Clearances |
|---|---|
| Acarix AS | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
